UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 42

Sortiert nach

Learning to distinguish progressive and non-progressive ductal carcinoma in situ

Nature reviews. Cancer, 2022-12, Vol.22 (12), p.663

2022

Link zum Volltext

Verfügbarkeit prüfen

Frequency of pathogenic germline variants in BRCA1, BRCA2, PALB2, CHEK2 and TP53 in ductal carcinoma in situ diagnosed in women under the age of 50 years

Breast cancer research : BCR, 2019-05, Vol.21 (1), p.58-58, Article 58

2019

Link zum Volltext

Verfügbarkeit prüfen

Intraoperative radiotherapy for early breast cancer - insufficient evidence to change practice

Nature reviews. Clinical oncology, 2020-12, Vol.17 (12), p.723-724

2020

Link zum Volltext

Verfügbarkeit prüfen

Reply to 'Intraoperative radiotherapy for breast cancer: powerful evidence to change practice'

Nature reviews. Clinical oncology, 2021-03, Vol.18 (3), p.188-189

2021

Link zum Volltext

Verfügbarkeit prüfen

SOX11 promotes invasive growth and ductal carcinoma in situ progression

The Journal of pathology, 2017-10, Vol.243 (2), p.193-207

2017

Link zum Volltext

Verfügbarkeit prüfen

Frequency of Pathogenic Germline Variants in CDH1, BRCA2, CHEK2, PALB2, BRCA1 , and TP53 in Sporadic Lobular Breast Cancer

Cancer epidemiology, biomarkers & prevention, 2019-07, Vol.28 (7), p.1162-1168

2019

Link zum Volltext

Verfügbarkeit prüfen

Mutation detection in saliva from oral cancer patients

Oral oncology, 2024-04, Vol.151, p.106717-106717, Article 106717

2024

Link zum Volltext

Verfügbarkeit prüfen

Epigenetic activation of SOX11 is associated with recurrence and progression of ductal carcinoma in situ to invasive breast cancer

British journal of cancer, 2024-07, Vol.131 (1), p.171-183

2024

Link zum Volltext

Verfügbarkeit prüfen

MED12, TERT promoter and RBM15 mutations in primary and recurrent phyllodes tumours

British journal of cancer, 2018-01, Vol.118 (2), p.277-284

2018

Link zum Volltext

Verfügbarkeit prüfen

Dose-escalated simultaneous integrated boost radiotherapy in early breast cancer (IMPORT HIGH): a multicentre, phase 3, non-inferiority, open-label, randomised controlled trial

The Lancet (British edition), 2023-06, Vol.401 (10394), p.2124-2137

2023

Link zum Volltext

Verfügbarkeit prüfen

Application of deep learning on mammographies to discriminate between low and high-risk DCIS for patient participation in active surveillance trials

Cancer imaging, 2024-04, Vol.24 (1), p.48-48, Article 48

2024

Link zum Volltext

Verfügbarkeit prüfen

PIK3CA mutations are common in lobular carcinoma in situ, but are not a biomarker of progression

Breast cancer research : BCR, 2017-01, Vol.19 (1), p.7-7, Article 7

2017

Link zum Volltext

Verfügbarkeit prüfen

The radiological features, diagnosis and management of screen-detected lobular neoplasia of the breast: Findings from the Sloane Project

Breast (Edinburgh), 2016-06, Vol.27, p.109-115

2016

Link zum Volltext

Verfügbarkeit prüfen

Molecular Analysis of Phyllodes Tumors Reveals Distinct Changes in the Epithelial and Stromal Components

The American journal of pathology, 2000-03, Vol.156 (3), p.1093-1098

2000

Link zum Volltext

Verfügbarkeit prüfen

The Wnt pathway, epithelial-stromal interactions, and malignant progression in phyllodes tumours

The Journal of pathology, 2002-04, Vol.196 (4), p.437-444

2002

Link zum Volltext

Verfügbarkeit prüfen

Malignant phyllodes tumours show stromal overexpression of c-myc and c-kit

The Journal of pathology, 2003-05, Vol.200 (1), p.59-64

2003

Link zum Volltext

Verfügbarkeit prüfen

Genomic characterisation of breast fibroepithelial lesions in an international cohort

The Journal of pathology, 2019-12, Vol.249 (4), p.447-460

2019

Link zum Volltext

Verfügbarkeit prüfen

Microcalcification crystallography as a potential marker of DCIS recurrence

Scientific reports, 2023-06, Vol.13 (1), p.9331-9331, Article 9331

2023

Link zum Volltext

Verfügbarkeit prüfen

β-catenin abnormalities and associated insulin-like growth factor overexpression are important in phyllodes tumours and fibroadenomas of the breast

The Journal of pathology, 2003-08, Vol.200 (5), p.627-632

2003

Link zum Volltext

Verfügbarkeit prüfen

Genetic differences between benign phyllodes tumors and fibroadenomas revealed through targeted next generation sequencing

Modern pathology, 2021-07, Vol.34 (7), p.1320-1332

2021

Link zum Volltext

Verfügbarkeit prüfen

MSI-low, a real phenomenon which varies in frequency among cancer types

The Journal of pathology, 2003-11, Vol.201 (3), p.389-394

2003

Link zum Volltext

Verfügbarkeit prüfen

Partial-breast radiotherapy after breast conservation surgery for patients with early breast cancer (UK IMPORT LOW trial): 5-year results from a multicentre, randomised, controlled, phase 3, non-inferiority trial

The Lancet (British edition), 2017-09, Vol.390 (10099), p.1048-1060

2017

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 42

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(41)
Mit Volltextzugriff
(36)

Publikationsform

Artikel
(42)

Sprache

Englisch
(42)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Learning to distinguish progressive and non-progressive ductal carcinoma in situ

Frequency of pathogenic germline variants in BRCA1, BRCA2, PALB2, CHEK2 and TP53 in ductal carcinoma in situ diagnosed in women under the age of 50 years

Intraoperative radiotherapy for early breast cancer - insufficient evidence to change practice

Reply to 'Intraoperative radiotherapy for breast cancer: powerful evidence to change practice'

Germline mutations affecting the proofreading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas

SOX11 promotes invasive growth and ductal carcinoma in situ progression

Frequency of Pathogenic Germline Variants in CDH1, BRCA2, CHEK2, PALB2, BRCA1 , and TP53 in Sporadic Lobular Breast Cancer

Mutation detection in saliva from oral cancer patients

Epigenetic activation of SOX11 is associated with recurrence and progression of ductal carcinoma in situ to invasive breast cancer

MED12, TERT promoter and RBM15 mutations in primary and recurrent phyllodes tumours

Dose-escalated simultaneous integrated boost radiotherapy in early breast cancer (IMPORT HIGH): a multicentre, phase 3, non-inferiority, open-label, randomised controlled trial

E-Cadherin/ROS1 Inhibitor Synthetic Lethality in Breast Cancer

Genetic susceptibility to radiation-induced breast cancer after Hodgkin lymphoma

Application of deep learning on mammographies to discriminate between low and high-risk DCIS for patient participation in active surveillance trials

PIK3CA mutations are common in lobular carcinoma in situ, but are not a biomarker of progression

The radiological features, diagnosis and management of screen-detected lobular neoplasia of the breast: Findings from the Sloane Project

Molecular Analysis of Phyllodes Tumors Reveals Distinct Changes in the Epithelial and Stromal Components

The Wnt pathway, epithelial-stromal interactions, and malignant progression in phyllodes tumours

Malignant phyllodes tumours show stromal overexpression of c-myc and c-kit

Genomic characterisation of breast fibroepithelial lesions in an international cohort

Microcalcification crystallography as a potential marker of DCIS recurrence

β-catenin abnormalities and associated insulin-like growth factor overexpression are important in phyllodes tumours and fibroadenomas of the breast

Genetic differences between benign phyllodes tumors and fibroadenomas revealed through targeted next generation sequencing

MSI-low, a real phenomenon which varies in frequency among cancer types

Partial-breast radiotherapy after breast conservation surgery for patients with early breast cancer (UK IMPORT LOW trial): 5-year results from a multicentre, randomised, controlled, phase 3, non-inferiority trial

Suchergebnisse filtern